To assess whether there was a difference in the therapeutic effect on renal fibrosis between Sup-ASCs and Deep-ASCs, we investigated α-SMA expression in the IRI model that had been administered PBS, Sup-ASCs, or Deep-ASCs. Here, ACTA1 is linked to renal fibrosis.